Proteomic and Metabolomic Signatures as Predictive Biomarkers in Cancer. Current Pharmaceutical Letters And Reviews, [S. l.], v. 2, n. 4, p. 20–27, 2026. DOI: 10.62896/. Disponível em: https://cplr.in/index.php/files/article/view/142.. Acesso em: 12 feb. 2026.